Enhancing Solubility and Dissolution Rate of Antifungal Drug Ketoconazole through Crystal Engineering

Abstract

To improve the solubility and dissolution rate of the BCS class II drug ketoconazole, five novel solid forms in 1:1 stoichiometry were obtained upon liquid-assisted grinding, slurry, and slow evaporation methods in the presence of coformers, namely, glutaric, vanillic, 2,6-dihydroxybenzoic, protocatechuic, and 3,5-dinitrobenzoic acids. Single-crystal X-ray diffraction analysis revealed that the hydroxyl/carboxylic acid. . .N-imidazole motif acts as the dominant supramolecular interaction in the obtained solid forms. The solubility of ketoconazole in distilled water significantly increased from 1.2 to 2165.6, 321.6, 139.1, 386.3, and 191.7 μg mL−1 in the synthesized multi-component forms with glutaric, vanillic, 2,6-dihydroxybenzoic, protocatechuic, and 3,5-dinitrobenzoic acid, respectively. In particular, the cocrystal form with glutaric acid showed an 1800-fold solubility increase in water concerning ketoconazole. Our study provides an alternative approach to improve the solubility and modify the release profile of poorly water-soluble drugs such as ketoconazole.

Two Novel Metformin Carboxylate Salts and the Accidental Discovery of Two 1,3,5-Triazine Antihyperglycemic Agent

“…In addition, The CO and C–O bond lengths of fumaric acid are 1.224 and 1.293 Å, and that of cinnamic acid are 1.259 and 1.279 Å, whereas the CO and C–O bond lengths of carboxylic acids in CSL 1 and CSL 2 were 1.242 and 1.262 Å and 1.245 and 1.258 Å. This implies that even though carboxylic acids tend to be asymmetric, it is also possible to tell that the two form a salt based on the C–O bond distance. − …”

Antifungal Activity against Human and Plant Mycopathogens, and Green Synthesis of Silver Nanoparticles Exhibiting Such Activity

“…An especially alarming phenomenon is the increasing drug resistance, which is an even more serious problem due to the small arsenal of antifungal agents available on the market. Currently, the most commonly used systemic drugs are amphotericin B, nystatin, fluconazole, and itraconazole, but their solubility and bioavailability are not satisfactory [19][20][21]. In addition, their use is associated with the risk of side effects, such as allergic and severe skin reactions.…”

Gefitinib salts/cocrystals with phenolic acids as a promising solid-state approach to improve solubility

“…27 Salt and/or cocrystal formation represents a potential strategy for improving the physical and chemical properties of GEF. Characterized by their good solubility and permeability, low toxicity, and reliable safety, phenolic acids have been recognized as a class of potential efficient cocrystal formers (CCFs) for enhancing the poor physicochemical properties of active pharmaceutical ingredients (APIs), such as ketoconazole, 28 milrinone, 29 amantadine hydrochloride, 30 acyclovir, 31 temozolomide, 32 ambrisentan, 33 and voriconazole. 34 The carboxyl and hydroxy groups on the phenolic acid molecular skeleton serve as excellent acceptors and/or donors of hydrogen bonding synthons, facilitating the formation of various intermolecular interactions and creating favorable conditions for self-assembly.…”